China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA: 600062)
China flag China · Delayed Price · Currency is CNY
21.73
-0.25 (-1.14%)
Nov 13, 2024, 3:00 PM CST

China Resources Double-Crane Pharmaceutical Co.,Ltd. Statistics

Total Valuation

China Resources Double-Crane Pharmaceutical Co.,Ltd. has a market cap or net worth of CNY 22.31 billion. The enterprise value is 21.01 billion.

Market Cap 22.31B
Enterprise Value 21.01B

Important Dates

The last earnings date was Monday, October 28, 2024.

Earnings Date Oct 28, 2024
Ex-Dividend Date Nov 8, 2024

Share Statistics

China Resources Double-Crane Pharmaceutical Co.,Ltd. has 1.03 billion shares outstanding. The number of shares has decreased by -0.71% in one year.

Current Share Class n/a
Shares Outstanding 1.03B
Shares Change (YoY) -0.71%
Shares Change (QoQ) -0.06%
Owned by Insiders (%) 0.12%
Owned by Institutions (%) 11.59%
Float 399.81M

Valuation Ratios

The trailing PE ratio is 16.56 and the forward PE ratio is 12.69.

PE Ratio 16.56
Forward PE 12.69
PS Ratio 2.16
PB Ratio 2.20
P/TBV Ratio n/a
P/FCF Ratio 20.62
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.61, with an EV/FCF ratio of 19.42.

EV / Earnings 15.59
EV / Sales 2.04
EV / EBITDA 9.61
EV / EBIT 14.10
EV / FCF 19.42

Financial Position

The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.07.

Current Ratio 1.59
Quick Ratio 1.19
Debt / Equity 0.07
Debt / EBITDA 0.34
Debt / FCF 0.66
Interest Coverage 120.65

Financial Efficiency

Return on equity (ROE) is 12.07% and return on invested capital (ROIC) is 7.67%.

Return on Equity (ROE) 12.07%
Return on Assets (ROA) 5.63%
Return on Capital (ROIC) 7.67%
Revenue Per Employee 841,305
Profits Per Employee 109,858
Employee Count 12,269
Asset Turnover 0.65
Inventory Turnover 2.82

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +27.20% in the last 52 weeks. The beta is 0.14, so China Resources Double-Crane Pharmaceutical Co.,Ltd.'s price volatility has been lower than the market average.

Beta (5Y) 0.14
52-Week Price Change +27.20%
50-Day Moving Average 22.00
200-Day Moving Average 20.43
Relative Strength Index (RSI) 46.32
Average Volume (20 Days) 17,929,158

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, China Resources Double-Crane Pharmaceutical Co.,Ltd. had revenue of CNY 10.32 billion and earned 1.35 billion in profits. Earnings per share was 1.31.

Revenue 10.32B
Gross Profit 5.79B
Operating Income 1.42B
Pretax Income 1.54B
Net Income 1.35B
EBITDA 2.10B
EBIT 1.42B
Earnings Per Share (EPS) 1.31
Full Income Statement

Balance Sheet

The company has 2.71 billion in cash and 711.52 million in debt, giving a net cash position of 1.99 billion or 1.94 per share.

Cash & Cash Equivalents 2.71B
Total Debt 711.52M
Net Cash 1.99B
Net Cash Per Share 1.94
Equity (Book Value) 10.89B
Book Value Per Share 9.89
Working Capital 2.72B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.84 billion and capital expenditures -757.67 million, giving a free cash flow of 1.08 billion.

Operating Cash Flow 1.84B
Capital Expenditures -757.67M
Free Cash Flow 1.08B
FCF Per Share 1.05
Full Cash Flow Statement

Margins

Gross margin is 56.06%, with operating and profit margins of 13.79% and 13.06%.

Gross Margin 56.06%
Operating Margin 13.79%
Pretax Margin 14.95%
Profit Margin 13.06%
EBITDA Margin 20.30%
EBIT Margin 13.79%
FCF Margin 10.48%

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.91%.

Dividend Per Share 0.20
Dividend Yield 0.91%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 83.33%
Buyback Yield 0.71%
Shareholder Yield 1.62%
Earnings Yield 6.04%
FCF Yield 4.85%
Dividend Details

Stock Splits

The last stock split was on August 16, 2018. It was a forward split with a ratio of 1.2.

Last Split Date Aug 16, 2018
Split Type Forward
Split Ratio 1.2

Scores

China Resources Double-Crane Pharmaceutical Co.,Ltd. has an Altman Z-Score of 3.98.

Altman Z-Score 3.98
Piotroski F-Score n/a